Nelly Mauras, MD

Chief, Division of Endocrinology
Pediatric Endocrinologist

Department of Pediatrics
Division of Endocrinology

Education:

Undergraduate: Bachelor of Science (Chemistry), University of Puerto Rico, San Juan, Puerto Rico
Medical School: University of Puerto Rico School of Medicine, San Juan, Puerto Rico

Post Graduate Training:

Internship and Residency: Pediatrics, Mayo Graduate School of Medicine, Rochester, Minnesota
Fellowship: Pediatric Endocrinology, University of Virginia School of Medicine, Charlottesville, Virginia

Certification:

American Board of Pediatrics
American Board of Pediatrics/Endocrinology

Academic Appointment:

Professor of Pediatrics (Mayo Medical School)

Publications (articles):

Mauras N, Kollman C, Steffes MW, Singh R, Fiallo-Scharer R, Weinzimer S, Buckingham B, Beck RW, Ruedy KJ, Xing D, Tamborlane WV. Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes. (Submitted 2007)
Mauras N, Gonzalez de Pijem L, Hsiang H, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Miyamoto A, Bishop K. Safety and Efficacy of Anastrozole in Increasing Predicted Adult Height of Adolescent Males with Growth Hormone Deficiency: A Randomized, Double-blind, Placebo-controlled Multicenter Trial (Submitted 2007)
Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S. Oral vs. Transdermal Estrogen replacement in GH-treated girls with Turner Syndrome:Metabolic Effects(J Clin Endocrinol Metab In press 2007)
Olney RC, Prickett TC, Yandle TG, Espiner EA, Han JC, Mauras N. Amino Terminal Propeptide of C-Natriuretic Peptide and Linear Growth in Children: Effects of Puberty, Testosterone and GH. J Clin Endocrinol Metab Aug 7,2007 [E pub ahead of Print]
Mauras N, Bishop K, Welch S. Growth hormone action in puberty: Effects by gender. Growth Horm IGF Res. Jun 11, 2007; [Epub ahead of print]
Mauras N Growth Hormone and Testosterone: Effects on Whole Body Metabolism and Skeletal Muscle in Adolescence. Horm Res. 2006;66 Suppl 1:42-48.
Le Bacquer O, Mauras N, Welch S, Haymond MW, Darmaun D. Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. Clin Nutr.26:231-8, 2007.
Diabetes Research in Children Network (DirecNet) Study Group. Impaired Overnight Counterregulatory Hormone Responses to Spontaneous Hypoglycemia in Children with Type 1 Diabetes Pediatr Diab 8(4):199-205, 2007 (Mauras N, chair, writing committee)
Diabetes Research in Children Network (DirecNet) Study Group: Positive Impact of FreeStyle Navigator™ Continuous Glucose Monitoring System Use in Children with Type 1 Diabetes: Results of a Pilot Trial J Pediatr (In press 2007) (*Mauras N, member writing committee)
Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Mauras N, White NH. Randomized trial of behavioral family systems therapy for diabetes: maintenance of effects on diabetes outcomes in adolescents. Diabetes Care 30:555-60, 2007
Diabetes Research in Children Network (DirecNet) Study Group: Relative accuracy of the BD Logic and FreeStyle blood glucose meters. Diabetes Technol Ther. 9:165-8, 2007(*Mauras N, member steering committee)
Diabetes Research in Children Network (DirecNet) Study Group: Relative inaccuracy of the A1C now in children with type 1 diabetes. Diabetes Care 30:135-137, 2007 (*Mauras N, member steering committee)
Diabetes Research in Children Network (DirecNet) Study Group: The Accuracy of the FreeStyle Navigator™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Care Diabetes Care. 30:59-64, 2007 (*Mauras N, member steering committee)
Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending Basal insulin. Diabetes Care 29:2200-4, 2006 (Mauras N, member, writing committee)
Wysocki T, Harris MA, Buckloh L, Mertlich D, Lochrie AS, Taylor A, Sadler M, Mauras N, White NH. Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence, and metabolic control. J Pediatr Psychol 31:925-938, 2006
Tansey MJ, Tsalikian E, Beck RW, Mauras N, Buckingham BA, Weinzimer SA, Janz KF, Kollman C, Xing D, Ruedy KJ, Steffes MW, Borland TM, Singh RJ, Tamborlane WV; The Diabetes Research in Children Network (DirecNet) Study Group. The effects of aerobic exercise on glucose and couterregulatory hormone concentrations in children with type 1 diabetes. Diab Care 29: 20-25, 2006. (Mauras N, member, writing committee)
Han JC, Balagopal P, Sweeten S, Darmaun D, Mauras N. Evidence for hypermetabolism in boys with constitutional delay of growth and maturation. J Clin Endocrinol Metab 91: 2081-2086, 2006.
Diabetes Research in Children Network (DirecNet) Study Group. Buckingham BA, Kollman C, Beck R, Kalajiian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, Tamborlane WV. Evaluation of factors affecting CGMS calibration. Diabetes Techol Ther 8: 18-25, 2006. (Mauras N, member, steering committee)
Diabetes Research in Children Network (DirecNet) Study Group. Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 7: 32-38, 2006. (Mauras N, member, steering committee)
Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T, Jr., Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab 2005; 90(12):6424-6430.
Weinzimer SA, Beck RW, Chase HP, Buckingham BA, Tamborlane WV, Kollman C, Coffey J, Xing D, Ruedy KJ. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther 2005; 7(5):675-680. *Mauras N, member, DirecNet steering committee.
Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, Wysocki T, Weinzimer SA, Buckingham BA, Kollman C, Xing D, Ruedy KJ. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005; 147(4):528-534.
Fiallo-Scharer R. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab 2005; 90(6):3387-3391. *Mauras N, member, DirecNet writing committee.
Diabetes Research in Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005; 28(8):1929-1935. *Mauras N, member, DirecNet steering committee.
Diabetes Research in Children Network (DirecNet) Study Group. Diabetes self-management profile for flexible insulin regimens: cross-sectional and longitudinal analysis of psychometric properties in a pediatric sample. Diabetes Care 2005; 28(8):2034-2035. *Mauras N, member, DirecNet steering committee.
Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 2005; 90(7):3946-3955.
Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005; 28(6):1277-1281.
Wysocki T, Harris MA, Buckloh LM, Wilkinson K, Sadler M, Mauras N, White NH. Self-Care Autonomy and Outcomes of Intensive Therapy or Usual Care in Youth with Type 1 Diabetes. J Pediatr Psychol 2005.
Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28(5):1101-1106.
Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005; 6(1):13-16. *Mauras N, member, DirecNet steering committee.
Lima JJ, Mauras N, Kissoon N, Wang J, Wiltrout SA, Sylvester JE. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis. Metabolism 2005; 54(4):492-499.
Mauras N, Bell J, Snow BG, Winslow KL. Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: comparison with normal controls. Fertil Steril 2005; 84(1):239-242.
Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther 2005; 7(1):109-114.
Mauras N, Haymond MW. Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 2005; 15(1):19-27.
Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005; 26(1):114-146.
Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 2005; 54(1):190-196.
Tsalikian E, Beck RW, Kalajian A, Janz KF, Tansey MJ. Function of the GlucoWatch G2 Biographer during exercise. Diabetes Technol Ther 2005; 7(1):230. *Mauras N, member, DirecNet steering committee.
Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, Beck R, Ruedy K, Tamborlane W, Fiallo-Scharer R. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther 2004; 6(5):559-566.
Mauras N, Welch S, Rini A, Klein KO. An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys. J Pediatr Endocrinol Metab 2004; 17(12):1597-1606.
Darmaun D, Hayes V, Schaeffer D, Welch S, Mauras N. Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. J Clin Endocrinol Metab 2004; 89(3):1146-1152.
Mauras N, Beck RW, Ruedy KJ, Kollman C, Tamborlane WV, Chase HP, Buckingham BA, Tsalikian E, Weinzimer S, Booth AD, Xing D. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr 2004; 144(6):770-775.
Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care 2004; 27(3):722-726. *Mauras N, member, DirecNet steering committee.
Mauras N, Lima J, Patel D, Rini A, di Salle E, Kwok A, Lippe B. Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males. J Clin Endocrinol Metab 2003; 88(12):5951-5956.
Diabetes Research in Children Network (DirecNet) Study Group. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther 2003; 5(6):933-941. *Mauras N, member, DirecNet steering committee.
Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003; 5(5):791-800. *Mauras N, member, DirecNet writing committee.
Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003; 5(5):781-789. *Mauras N, member, DirecNet writing committee.
Wysocki T, Harris MA, Mauras N, Fox L, Taylor A, Jackson SC, White NH. Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 2003; 26(4):1100-1105.
Wysocki T, Harris MA, Wilkinson K, Sadler M, Mauras N, White NH. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care 2003; 26(7):2043-2047.
Mauras N, Rini A, Welch S, Sager B, Murphy SP. Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 2003; 52(8):964-969.
Balagopal P, Sweeten S, Mauras N. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab 2002; 282(4):E899-E904.
Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 2002; 51(1):127-135.
Mauras N. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. Horm Res 2001; 56 Suppl 1:13-18.
Hayes VY, Urban RJ, Jiang J, Marcell TJ, Helgeson K, Mauras N. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects. J Clin Endocrinol Metab 2001; 86(5):2211-2219.
Mauras N, Hayes V, OBrien KO. Estrogen treatment and estrogen suppression: metabolic effects in adolescence. J Pediatr Endocrinol Metab 2000; 13 Suppl 6:1431-1437.
Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 2000; 85(10):3653-3660.
Mauras N, Martinez V, Rini A, Guevara-Aguirre J. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. J Clin Endocrinol Metab 2000; 85(9):3036-3042.
Harris MA, Wysocki T, Sadler M, Wilkinson K, Harvey LM, Buckloh LM, Mauras N, White NH. Validation of a structured interview for the assessment of diabetes self-management. Diabetes Care 2000; 23(9):1301-1304.
Mauras N, OBrien KO, Klein KO, Hayes V. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 2000; 85(7):2370-2377.
Mauras N, Walton P, Nicar M, Welch S, Rogol AD. Growth hormone stimulation testing in both short and normal statured children: use of an immunofunctional assay. Pediatr Res 2000; 48(5):614-618.
Mauras N, OBrien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 2000; 85(4):1686-1694.
Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med 1999; 341(16):1206-1216.
Hankard R, Mauras N, Hammond D, Haymond M, Darmaun D. Is glutamine a conditionally essential amino acid in Duchenne muscular dystrophy? Clin Nutr 1999; 18(6):365-369.
Mauras N, Quarmby V, Bloedow DC. Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteins. Am J Physiol 1999; 277(4 Pt 1):E579-E584.
Mauras N. Growth hormone, insulin-like growth factor I and sex hormones: effects on protein and calcium metabolism. Acta Paediatr Suppl 1999; 88(433):81-83.
Mauras N, Hayes VY, Vieira NE, Yergey AL, OBrien KO. Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study. J Bone Miner Res 1999; 14(4):577-582.
Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP. Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics 1998; 102(2 Pt 3):486-488.
Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis JD, Urban RJ. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998; 83(6):1886-1892.
Mauras N, Welch S, Rini A, Haymond MW. Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study. J Clin Endocrinol Metab 1998; 83(6):1900-1905.
Veldhuis JD, Metzger DL, Martha PM, Jr., Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997; 82(10):3414-3420.
Mauras N, Martha PM, Jr., Quarmby V, Haymond MW. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery. Am J Physiol 1997; 272(4 Pt 1):E628-E633.
Mauras N, Vieira NE, Yergey AL. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turners syndrome: a calcium kinetic study. Metabolism 1997; 46(8):908-913.
Goddard AD, Dowd P, Chernausek S, Geffner M, Gertner J, Hintz R, Hopwood N, Kaplan S, Plotnick L, Rogol A, Rosenfield R, Saenger P, Mauras N, Hershkopf R, Angulo M, Attie K. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. J Pediatr 1997; 131(1 Pt 2):S51-S55.
Haymond MW, Mauras N. The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans. Horm Res 1996; 46(4-5):202-207.
Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res 1996; 45(1-2):74-80.
Mauras N, Doi SQ, Shapiro JR. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans. J Clin Endocrinol Metab 1996; 81(6):2222-2226.
Mauras N, Haymond MW. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone. Pediatr Nephrol 1996; 10(3):318-323.
Robinson IC, Gabrielsson B, Klaus G, Mauras N, Holmberg C, Mehls O. Glucocorticoids and growth problems. Acta Paediatr Suppl 1995; 411:81-86.
Mauras N. Estrogens do not affect whole-body protein metabolism in the prepubertal female. J Clin Endocrinol Metab 1995; 80(10):2842-2845.
Mauras N. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects. J Clin Endocrinol Metab 1995; 80(9):2633-2637.
Mauras N, Beaufrere B. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab 1995; 80(3):869-874.
Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL. Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J Clin Invest 1994; 93(3):1014-1019.
Mauras N, Carlsson LM, Murphy S, Merimee TJ. Growth hormone-binding protein levels: studies of children with short stature. Metabolism 1994; 43(3):357-359.
Haymond MW, Horber FF, De Feo P, Kahn SE, Mauras N. Effect of human growth hormone and insulin-like growth factor I on whole-body leucine and estimates of protein metabolism. Horm Res 1993; 40(1-3):92-94.
Haymond MW, Horber FF, Mauras N. Human growth hormone but not insulin-like growth factor I positively affects whole-body estimates of protein metabolism. Horm Res 1992; 38 Suppl 1:73-75.
Mauras N, Horber FF, Haymond MW. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab 1992; 75(5):1192-1197.
Mauras N, Rogol AD, Veldhuis JD. Estrogenic modulation of the gonadotropin-releasing hormone-stimulated secretory activity of the gonadotrope and lactotrope in prepubertal females with Turners syndrome. J Clin Endocrinol Metab 1991; 73(6):1202-1209.
Mauras N, Merimee T, Rogol AD. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome. Metabolism 1991; 40(10):1106-1111.
Mauras N, Rogol AD, Veldhuis JD. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turners syndrome. Pediatr Res 1990; 28(6):626-630.
Blizzard RM, Martha PM, Kerrigan JR, Mauras N, Rogol AD. Changes in growth hormone (GH) secretion and in growth during puberty. J Endocrinol Invest 1989; 12(8 Suppl 3):65-68.
Mauras N, Rogol AD, Veldhuis JD. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turners syndrome. J Clin Endocrinol Metab 1989; 69(5):1053-1058.
Mauras N, Blizzard RM, Rogol AD. Androgen-dependent somatotroph function in a hypogonadal adolescent male: evidence for control of exogenous androgens on growth hormone release. Metabolism 1989; 38(3):286-289.
Mauras N, Sabio H, Rogol AD. Neuroendocrine function in survivors of childhood acute lymphocytic leukemia and non-Hodgkins lymphoma: a study of pulsatile growth hormone and gonadotropin secretions. Am J Pediatr Hematol Oncol 1988; 10(1):9-17.
Mauras N, Rogol AD, Veldhuis JD. Appraising the instantaneous secretory rates of luteinizing hormone and testosterone in response to selective mu opiate receptor blockade in late pubertal boys. J Androl 1987; 8(4):203-209.
Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD. Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 1987; 64(3):596-601.
Mauras N, Blizzard RM, Thorner MO, Rogol AD. Selective beta 1-adrenergic receptor-blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man. Metabolism 1987; 36(4):369-372.
Velduis JD, Weiss J, Mauras N, Rogol AD, Evans WS, Johnson ML. Appraising endocrine pulse signals at low circulating hormone concentrations: use of regional coefficients of variation in the experimental series to analyze pulsatile luteinizing hormone release. Pediatr Res 1986; 20(7):632-637.
Mauras N, Veldhuis JD, Rogol AD. Role of endogenous opiates in pubertal maturation: opposing actions of naltrexone in prepubertal and late pubertal boys. J Clin Endocrinol Metab 1986; 62(6):1256-1263.
Mauras N, Rogol AD, Clarke WL. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion. J Clin Endocrinol Metab 1986; 62(5):975-979.
Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) 1986; 279:207-217.
Mauras N, Zimmerman D, Goellner JR. Hashimoto thyroiditis associated with thyroid cancer in adolescent patients. J Pediatr 1985; 106(6):895-898.

Publications (book chapters):

Mauras N. GH, sex steroids and IGF-I: metabolic effects in puberty and beyond. In: Pescovitz OH, Eugster EA, editors. Pediatric Endocrinology: Mechanisms, Manifestations and Management. Philadelphia: Lippincott Williams & Wilkins, 2004.
Mauras N. Metabolic effects of insulin-like growth factor I and growth hormone in vivo: a comparison. In: LeRoith D, Zumkeller W, Baxter RC, editors. Insulin-Like Growth Factors. Georgetown, TX: Landes Bioscience, 2003.
Mauras N. GH and sex steroids: Interactions in puberty. In: Klibanski A, editor. Neuroendocrine Clinics of North America. Philadelphia: W.B. Saunders, 2001.
Mauras N. Metabolic effects of GH/IGF-I, testosterone and estrogen: studies in children and adults. In: Veldhuis JD, Giustina A, editors. Sex-Steroid Interactions with Growth Hormone. New York: Springer-Verlag, Inc., 1999.
Mauras N. Growth & Adolescent Disorders. In: Klibanski A, Biller BMK, editors. Clinical Endocrinology Update, 1998 Syllabus. 1998: 97-105.
Rogol AD, Link K, Romero G, Ball M, Martha P, Mauras N, Parker M, Nieves-Rivera F, Blizzard RM. Alterations in growth hormone release during pubertal development in boys. In: Grave G, Cutler G, editors. Sexual Precocity: Etiology, Diagnosis and Management. New York: Raven Press, 1993: 121-132.
Martha PM, Rogol A, Mauras N, Kerrigan JR, Blizzard RM. Growth hormone secretion in puberty. In: Delemarre-van de Wall HA, Plant TM, Van Rees GP, Schoemaker J, editors. Control of the Onset of Puberty III. New York: Elsevier Science Pub. Co., 1989: 319-327.
Rogol A, Blizzard RM, Mauras N, Link K, Vance ML, Ho KY, Evans WS, Veldhuis JD, Thorner MO. Pulsatile growth hormone secretion. In: Wagner TOF, Filicori M, editors. Episodic Hormone Secretion: From Basic Science to Clinical Application. Hamelosterstr, FRG: T.M. Verlag, 1987.
Mauras N, Blizzard RM. The McCune - Albright Syndrome. In: Illig R, Visser HKA, editors. Pediatric Endocrinology. Copenhagen: Acta Endocrinol Suppl, 1986: 207-217.